|
NCT00537953
|
|
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
|
Phase 2
|
Recruiting
|
|
NCT02233972
|
2014-08-01 |
A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam
|
Phase 4
|
Completed
|
|
NCT02264535
|
2014-06-01 |
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.
|
Phase 4
|
Completed
|
|
NCT02046031
|
2014-02-01 |
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
|
Phase 4
|
Completed
|
|
NCT01953744
|
2014-01-01 |
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
|
Phase 3
|
Not Yet Recruiting
|
|
NCT01958957
|
2013-06-01 |
A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
|
Phase 4
|
Completed
|
|
NCT01806740
|
2013-03-01 |
DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
|
Phase 4
|
Recruiting
|
|
NCT01464242
|
2011-11-01 |
Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT01369836
|
2011-07-01 |
Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects
|
Phase 1
|
Completed
|
|
NCT01050777
|
2011-03-01 |
Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
|
Phase 0
|
Completed
|
|
NCT01211873
|
2010-09-01 |
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
|
Phase 3
|
Completed
|
|
NCT00845702
|
2009-04-01 |
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
|
Phase 3
|
Terminated
|
|
NCT01301924
|
2008-10-01 |
Comparison of Low and High Antimonial Dosage in American Cutaneous Leishmaniasis
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT01301937
|
2008-10-01 |
Low Antimonial Dosage in American Mucosal Leishmaniasis
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT00818818
|
2008-08-01 |
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
|
Phase 4
|
Completed
|
|
NCT01032187
|
2007-10-01 |
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
|
Phase 4
|
Completed
|
|
NCT00487253
|
2007-07-01 |
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00600548
|
2007-07-01 |
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
|
Phase 2
|
Completed
|
|
NCT00317629
|
2006-05-01 |
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
|
Phase 3
|
Terminated
|
|
NCT00317980
|
2006-02-01 |
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
|
Phase 4
|
Completed
|
|
NCT00973128
|
2004-02-01 |
Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis
|
Phase 2
|
Completed
|